- Home
- AIRG vs MRSN Comparison
AIRG vs MRSN Comparison
Compare AIRG & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRG
- MRSN
- Stock Information
- Founded
- AIRG 1995
- MRSN 2001
- Country
- AIRG United States
- MRSN United States
- Employees
- AIRG N/A
- MRSN N/A
- Industry
- AIRG Radio And Television Broadcasting And Communications Equipment
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- AIRG Technology
- MRSN Health Care
- Exchange
- AIRG Nasdaq
- MRSN Nasdaq
- Market Cap
- AIRG 49.2M
- MRSN 47.1M
- IPO Year
- AIRG 2016
- MRSN 2017
- Fundamental
- Price
- AIRG $4.16
- MRSN $8.00
- Analyst Decision
- AIRG Strong Buy
- MRSN Strong Buy
- Analyst Count
- AIRG 3
- MRSN 3
- Target Price
- AIRG $8.50
- MRSN $33.00
- AVG Volume (30 Days)
- AIRG 29.2K
- MRSN 60.7K
- Earning Date
- AIRG 11-12-2025
- MRSN 11-13-2025
- Dividend Yield
- AIRG N/A
- MRSN N/A
- EPS Growth
- AIRG N/A
- MRSN N/A
- EPS
- AIRG N/A
- MRSN N/A
- Revenue
- AIRG $56,820,000.00
- MRSN $34,769,000.00
- Revenue This Year
- AIRG N/A
- MRSN N/A
- Revenue Next Year
- AIRG $21.58
- MRSN N/A
- P/E Ratio
- AIRG N/A
- MRSN N/A
- Revenue Growth
- AIRG 6.84
- MRSN 16.14
- 52 Week Low
- AIRG $3.17
- MRSN $5.21
- 52 Week High
- AIRG $10.34
- MRSN $70.75
- Technical
- Relative Strength Index (RSI)
- AIRG 51.84
- MRSN 41.31
- Support Level
- AIRG $3.95
- MRSN $8.00
- Resistance Level
- AIRG $4.35
- MRSN $9.87
- Average True Range (ATR)
- AIRG 0.19
- MRSN 0.64
- MACD
- AIRG 0.01
- MRSN -0.30
- Stochastic Oscillator
- AIRG 65.12
- MRSN 6.44
About AIRG Airgain Inc.
Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.